Book tickets for Pivotal Links 2024, Oxford UK, 17-18th June 2024

Our Transactions

We combine deep, personal industry knowledge and M&A experience in biotechnology to support our clients in developing and executing their M&A strategy.

Ba 5

Our track record

Since 2019, we have completed 70+ biotechnology strategy reviews, undertaken 20+ sell-side transactions & 40+ buy-side projects.

Whilst much of our work in the M&A space is confidential, a selection of our completed projects are listed below.

We support a broad set of transactions, including:

  • Mergers
  • Acquisitions
  • Management-led buyouts
  • Disposals (assets and stock)
  • Specialist Commercial Due Diligence (CDD)

We have a proprietary database of sellers globally, covering manufacturers, distributors and hybrid resellers.

PIVOTAL_LINKS_213092
European life science distribution companies Veterinary diagnostics distributors
IVD Reagents and raw materials Life science reagent distributors
Manufactures of antibodies, kits and proteins IVD reagent and raw materials

Recent Transactions

2b Newmarket

Newmarket Scientific Acquired by 2BScientific

Pivotal Scientific Limited is pleased to have supported 2BScientific Limited as they enter an asset purchase agreement with Newmarket Scientific Limited by providing M&A advisory…

Read More »

Parel Llc Percorso Web

Percorso acquired by Parel Bio, LLC 

6th November, London, UK – Life Science Logistics firm Percorso Life Sciences today announced their acquisition by Parel Bio, LLC.  Pivotal Scientific Limited (PSL) exclusively…

Read More »

Lgc Acquires Virusys

Virusys Corporation acquired by LGC

Virusys approached Pivotal Scientific Limited (PSL) to exclusively manage the sale of the company, having been recommended…

Read More »

Fortis Abcore

Abcore is Acquired by Fortis Life Sciences

Abcore approached Pivotal Scientific to exclusively manage the sale of the company to Fortis Life Sciences, trusting our previous support and recognizing our skills in M&A…

Read More »

Chromocyte Biocompare2

Chromocyte is Acquired by Biocompare

The Chromocyte Journey from startup to maturity to acquisition: Pivotal Scientific has assisted Chromocyte throughout its business lifecycle. We are delighted to have supported it…

Read More »

Arlington Scientific acquires non-mammalian blocking buffer product line from Clark McDermith

Pivotal Scientific are pleased to announce their involvement in Arlington Scientific, Inc. acquiring the non-mammalian blocking buffer product line from Clark McDermith, former owner of East…

Read More »

Atlas

Pivotal Scientific advises Atlas Antibodies on its purchase of Evitria

Pivotal Scientific Limited supported Atlas Antibodies in their decision making on the purchase of Evitria by undertaking commercial due diligence and providing expert advisory services. Atlas Antibodies wanted to make…

Read More »

Nordic Scicons

Pivotal Scientific advises Nordic-MUbio on its purchase of SCICONS

Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Hungarian based Biotechnology company SCICONS to Nordic MUbio based in the…

Read More »